Lesson of the Month - Comparative expression of calretinin in selected odontogenic tumours: a possible relationship to histogenesis

被引:20
作者
Alaeddini, M. [1 ]
Etemad-Moghadam, S. [1 ]
Baghaii, F. [2 ]
机构
[1] Univ Tehran Med Sci, Dent Res Ctr, Fac Dent, Tehran 14174, Iran
[2] Univ Tehran Med Sci, Dept Oral Pathol, Fac Dent, Tehran 14174, Iran
关键词
ameloblastoma; calcium-binding protein; calretinin; immunohistochemistry; odontogenic tumours;
D O I
10.1111/j.1365-2559.2007.02948.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: Calretinin, a calcium-binding protein, is expressed primarily in certain subtypes of neurons. It has also been reported to be present in mesotheliomas and other tumours. The aim was to determine the expression of calretinin in selected odontogenic neoplasms. Methods and results: Immunohistochemistry for calretinin was performed on 55 odontogenic tumours consisting of 20 solid ameloblastomas, five calcifying epithelial odontogenic tumours, 10 adenomatoid odontogenic tumours, 10 ameloblastic fibromas and 10 odontogenic myxomas. The distribution, intensity, pattern and localization of immunoreactive cells were determined by conventional light microscopy. chi(2) test was used for statistical analysis and P < 0.05 was considered to be significant. All 20 ameloblastomas showed intense immunopositivity with a diffuse distribution pattern. None of the other neoplasms was reactive with calretinin. Differences in the proportion of calretinin expression between groups were statistically significant at P < 0.001. Conclusions: Considering that ameloblastomas, in contrast to the other studied tumours, were consistently reactive for calretinin, this protein may have a role in the pathogenesis of this aggressive neoplasm.
引用
收藏
页码:299 / 304
页数:6
相关论文
共 25 条
[1]   Calretinin expression in ameloblastomas [J].
Altini, M ;
Coleman, H ;
Doglioni, C ;
Favia, G ;
Maiorano, E .
HISTOPATHOLOGY, 2000, 37 (01) :27-32
[2]   CALCIUM-BINDING PROTEINS - SELECTIVE MARKERS OF NERVE-CELLS [J].
ANDRESSEN, C ;
BLUMCKE, I ;
CELIO, MR .
CELL AND TISSUE RESEARCH, 1993, 271 (02) :181-208
[3]  
Augusto D, 2002, APPL IMMUNOHISTO M M, V10, P159, DOI 10.1097/00022744-200206000-00011
[4]  
Barnes L, 2005, PATHOLOGY GENETICS H, P283
[5]  
CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395
[6]   Use of calretinin in the differential diagnosis of unicystic ameloblastomas [J].
Coleman, H ;
Altini, M ;
Ali, H ;
Doglioni, C ;
Favia, G ;
Maiorano, E .
HISTOPATHOLOGY, 2001, 38 (04) :312-317
[7]  
Dei Tos A P, 1998, Adv Anat Pathol, V5, P61
[8]   Calretinin: A novel immunocytochemical marker for mesothelioma [J].
Doglioni, C ;
Tos, APD ;
Laurino, L ;
Iuzzolino, P ;
Chiarelli, C ;
Celio, MR ;
Viale, G .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (09) :1037-1046
[9]   Odontogenic tumors: a study of 340 cases in a Brazilian population [J].
Fernandes, AM ;
Duarte, ECB ;
Pimenta, FJGS ;
Souza, LN ;
Santos, VR ;
Mesquita, RA ;
de Aguiar, MCF .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2005, 34 (10) :583-587
[10]   Inhibition of the proliferative cycle and apoptotic events in WiDr cells after down-regulation of the calcium-binding protein calretinin using antisense oligodeoxynucleotides [J].
Gander, JC ;
Gotzos, V ;
Fellay, B ;
Schwaller, B .
EXPERIMENTAL CELL RESEARCH, 1996, 225 (02) :399-410